White Mark Andrew 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Apr 10, 2024
Insider Transaction Report
Form 4
White Mark Andrew
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-04-08$24.64/sh−12,532$308,763→ 75,226 total
Footnotes (1)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years.